Bengal Physician Journal

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  11 (2024)
Volume  10 (2023)
Volume  9 (2022)
Volume  8 (2021)
Volume  7 (2020)
Volume  6 (2019)
Volume  5 (2018)
Related articles

VOLUME 7 , ISSUE 3 ( September-December, 2020 ) > List of Articles

REVIEW ARTICLE

Cytokine Storm

Satyabrata Ganguly, Tanuka Mandal

Citation Information : Ganguly S, Mandal T. Cytokine Storm. Bengal Physician Journal 2020; 7 (3):70-71.

DOI: 10.5005/jp-journals-10070-7037

License: CC BY-NC 4.0

Published Online: 01-12-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Abstract

Cytokine storm is said to occur when increased levels of cytokines are disproportionately produced, with systemic effect and collateral damage to vital organs. It can be caused by both intrinsic (autoimmune) or extrinsic (COVID-19) diseases. In the absence of pathogens, cytokine storm can occur due to immune hyperactivation as a result of inappropriate triggering. Interleukin-6, tumor necrosis factor α, and interleukin-18 are cytokines of clinical importance in cytokine storm. Interleukin-18, a biomarker of severity, correlates with hyperferritinemia and disease flare. The underlying condition should be detected and treatment should be individualized.

HTML PDF Share
  1. Clark IA. The advent of the cytokine storm. Immunol Cell Biol 2007;85(4):271–273. DOI: 10.1038/sj.icb.7100062. PMID: 17551531.
  2. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 2020;54:62–75. DOI: 10.1016/j.cytogfr.2020.06.001. PMID: 32513566; PMCID: PMC7265853.
  3. Mah AY, Cooper MA. Crit Rev Immunol 2016;36(2):131–147. DOI: 10.1615/CritRevImmunol.2016017387.
  4. Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med 2020;383(23):2255–2273. DOI: 10.1056/NEJMra2026131. PMID: 33264547; PMCID: PMC7727315.
  5. Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 2014;5:491. DOI: 10.3389/fimmu.2014.00491. PMID: 25339958; PMCID: PMC4188125.
  6. Schulert GS, Grom AA. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol 2014;28(2):277–292. DOI: 10.1016/j.berh.2014.03.002. PMID: 24974063; PMCID: PMC4074772.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.